STAA
Staar Surgical Co.

1,449
Mkt Cap
$1.33B
Volume
2.53M
52W High
$32.00
52W Low
$13.50
PE Ratio
-13.95
STAA Fundamentals
Price
$26.96
Prev Close
$24.90
Open
$24.98
50D MA
$27.10
Beta
1.25
Avg. Volume
769,673.57
EPS (Annual)
-$0.4114
P/B
3.95
Rev/Employee
$259,208.09
Loading...
Loading...
News
all
press releases
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon
Stocktwits·14h ago
News Placeholder
More News
News Placeholder
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the Implantable Collamer Lens (ICL...
Business Wire·15h ago
News Placeholder
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
Broadwood Partners, L.P. and its affiliates (Broadwood or we), which owns 27.5% of the outstanding common stock of STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA), notified the Companys...
Business Wire·2d ago
News Placeholder
Broadwood Partners Issues Letter to STAAR Surgicals Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ...
Business Wire·7d ago
News Placeholder
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
STAAR Surgical Company (NASDAQ: STAA) (STAAR), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today issued the following...
Business Wire·7d ago
News Placeholder
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon
Broadwood Partners, L.P. and its affiliates (Broadwood or we) today announced that Institutional Shareholder Services Inc. (ISS), a leading independent proxy advisory firm, has recommended that the...
Business Wire·9d ago
News Placeholder
Broadwood Partners Comments on STAAR Surgicals Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon
Broadwood Partners, L.P. and its affiliates (Broadwood or we) today commented on the recent Current Report on Form 8-K filed by STAAR Surgical Company (STAAR or the Company) (NASDAQ: STAA) with the...
Business Wire·10d ago
News Placeholder
Broadwood Partners Issues Letter to STAAR Surgicals Board Questioning Its Diligence in Rush to Reaffirm Support for Alcon Sale
Broadwood Partners, L.P. and its affiliates (collectively, Broadwood) today issued the following letter to the Board of Directors (the Board) of STAAR Surgical Company (STAAR or the Company) (NASDAQ...
Business Wire·14d ago
News Placeholder
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company
Defender Capital, which owns 1.5% of STAAR’s common stock, highlighted STAAR’s board of directors' rejection of Alcon's previous offer of $58 per share in cash.
Stocktwits·17d ago
News Placeholder
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why
Yunqi alleged in a letter to other shareholders that the proposed merger undervalues Staar and announced its intention to vote against the proposed sale.
Stocktwits·1mo ago

Latest STAA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.